Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Metformin × Clear all

Phase

Phase NA 3 Phase 1 3 Phase 4 2 Phase 2/3 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 117 NIH 4 INDUSTRY 2 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Hyperplasia 1

Interventions

Capecitabine 24 Cisplatin 21 tislelizumab 20 apatinib 20 Gemcitabine 20 Oxaliplatin 19 Paclitaxel 18 Irinotecan 17 Carboplatin 16 Docetaxel 15 Bevacizumab 13 Fluorouracil 12 Drug Therapy 11 pembrolizumab 10 camrelizumab 10 Cyclophosphamide 10 Radiation 9 Vinorelbine 8 S 1 (combination) 8 Rituximab 7 Erlotinib Hydrochloride 7 Cetuximab 7 Leucovorin 6 Albumin-Bound Paclitaxel 6 toripalimab 5 pyrotinib 5 fludarabine 5 Nivolumab 5 Injections 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡